James V Cassella
CIK 1353528 · Chief Development Officer · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
59
Lifetime Open-Market Net
-$658.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVI | Chief Development Officer | — | $14.21 | — | $0 | 9 | 2026-02-20 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Chief Development Officer | 0 | $8.37 | $0 | -$470.3K | 23 | 2023-03-06 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Former EVP, R&D and CSO | 18,745 | — | — | -$188.2K | 27 | 2015-05-04 |
Recent Filings · Page 3 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-18 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2019-08-19 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +31,100 | $0 | EDGAR |
| 2019-04-02 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −8,835 | -$106.6K | EDGAR |
| 2019-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-19 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Sell (S) | −10,582 | -$213.5K | EDGAR |
| 2018-04-13 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −4,418 | -$101.2K | EDGAR |
| 2018-04-03 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −4,418 | -$101.2K | EDGAR |
| 2018-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-10 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +60,000 | $0 | EDGAR |
| 2017-01-06 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.